ONCAlert | Upfront Therapy for mRCC
2018 ASH Annual Meeting
The 2018 American Society of Hematology Annual Meeting & Exposition, held at the San Diego Convention Center in San Diego, California, from December 1-4, 2018.
Consistent OS Benefit Seen Across Patient Subgroups With Quizartinib in AML
Jason M. Broderick
Durable Responses Achieved With Acalabrutinib in MCL
Wayne Kuznar
Key Findings Reviewed From ALCYONE Trial in Myeloma
Maria-Victoria Mateos, MD, PhD
